The Permian Basin's Walk to End Alzheimer's is coming up Oct. 26. The event opens at 9 a.m. at Scharbauer Sports Complex-Coterra Pavilion, 5514 Champions Drive, in Midland. The opening ceremony is at ...

On November 28, 1520, Portuguese navigator Ferdinand Magellan reached the Pacific Ocean after passing through the South American strait that now bears his name.

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

IBN ? Annovis Bio Inc. ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Listen to episode nine, “Executing Clinical Research in Dementia with Lewy Bodies (DLB)” on the Conversations tab of the Cognition website. This conversation is presented in 3 Chapters: 1) Comparing ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...

Researchers intrigued by people with hallmarks of Alzheimer’s disease — but none of the symptoms — have probed their brains in the search for a cure. They initially drew samples from the Netherlands ...